Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

661
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
661
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

728
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
728
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Second regulatory workshop on utilising in silico models to expedite vaccine development, testing, and lifecycle management - an expert meeting report.

Vaccine·2026
Same author

Assessing Readiness for Future Maternal Malaria Vaccines: Knowledge, Practices, and Vaccine Attitudes Among Women of Reproductive Age in Malawi.

Vaccines·2026
Same author

Barriers and Opportunities to Include Underrepresented Population Groups in Vaccine Trials: Cross-Sectional, Observational, Online Survey Study From the VACCELERATE Research Network.

JMIR public health and surveillance·2026
Same author

Placental malaria: a systematic review and meta-analysis of global burden, risk factors, and maternal and foetal outcomes.

Journal of global health·2025
Same author

Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting report.

Biologicals : journal of the International Association of Biological Standardization·2025
Same author

Boosting Vaccine Research: The 16-Year Journey of TRANSVAC Vaccine Infrastructure.

Vaccines·2025
Same journal

Functional Genomic Evidence for Candidate Small Viral RNA-Mediated Epigenetic Interference in SARS-CoV-1 and SARS-CoV-2.

Computational and structural biotechnology journal·2026
Same journal

From Pixels to Patterns: A Multidimensional Framework to Decode Cytoskeletal Organization.

Computational and structural biotechnology journal·2026
Same journal

A Large Concept Model for Mechanistic Simulation of Disease Trajectories: A Hypothesis-Generating Exemplar for Pediatric Acute Lymphoblastic Leukemia.

Computational and structural biotechnology journal·2026
Same journal

Adversarial Sequence Mutations in AlphaFold and ESMFold Reveal Nonphysical Structural Invariance, Confidence Failures, and Concerns for Protein Design.

Computational and structural biotechnology journal·2026
Same journal

High-Throughput Prediction of Protein-Protein Interactions Uncovers Hidden Molecular Networks in Biosynthetic Gene Clusters.

Computational and structural biotechnology journal·2026
Same journal

A Region-Aware Structured Framework Improves Prediction of Gene Expression from DNA Methylation.

Computational and structural biotechnology journal·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.7K

Increasing European Support for Neglected Infectious Disease Research.

Ole F Olesen1, Marit Ackermann1

  • 1European & Developing Countries Clinical Trials Partnership (EDCTP), Anna van Saksenlaan 51, 2593 HW, The Hague, The Netherlands.

Computational and Structural Biotechnology Journal
|February 10, 2017
PubMed
Summary
This summary is machine-generated.

The European Union significantly increased funding for neglected infectious diseases (NIDs) research during FP7, investing €169 million. This enhanced global collaboration and positioned Europe to lead in combating NIDs.

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.9K

Related Experiment Videos

Last Updated: Mar 7, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.7K
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.9K

Area of Science:

  • Global Health
  • Infectious Diseases
  • Research Funding

Background:

  • Neglected infectious diseases (NIDs) cause significant mortality and disability in low-income nations.
  • Existing treatments for NIDs are often inadequate, expensive, or have severe side effects.
  • Despite their burden, NIDs historically received limited research attention and investment.

Purpose of the Study:

  • To analyze European Union (EU) funding for neglected infectious diseases (NIDs) research during the 7th Framework Programme (FP7).
  • To assess the impact of EU investments on global NID research collaboration and capacity.
  • To evaluate Europe's position in addressing the global challenge of NIDs.

Main Methods:

  • Analysis of publicly available funding data from the EU's 7th Framework Programme for Research and Technological Development (FP7), covering 2007-2013.
  • Quantification of total and average annual investment in NID research projects.
  • Mapping of participating institutions and countries involved in FP7 NID research.

Main Results:

  • The EU allocated €169 million to 65 NID research projects under FP7, marking a threefold increase in annual investment compared to pre-FP7 levels.
  • Average annual FP7 investment in NID research exceeded €24 million.
  • FP7 NID research involved 331 institutions across 72 countries, highlighting a broad international scope.

Conclusions:

  • The EU emerged as a leading global funder of neglected infectious diseases (NIDs) research through FP7.
  • Continued EU commitment to NID research, exemplified by Horizon 2020 and EDCTP, strengthens Europe's role in developing new medical interventions.
  • Europe is strategically positioned to significantly contribute to the global fight against neglected infectious diseases.